In addition, Qu et al. [125] synthesized a class of FAK inhibitors, named Sul-DPPYs and it could effectively inhibit the activity of FAK and treat pancreatic cancer as a potent FAK inhibitor. Here, PTK2 is linked to pancreatic neoplasm.